FDA Approves t:slim Insulin Pump for Children Ages 6 and Older

FDA Approves t:slim Insulin Pump for Children Ages 6 and Older

The U.S. FDA has approved Tandem Diabetes Care’s t:slim Insulin Pump for use by children age 6 and older. Until now the t:slim Insulin Pump was approved for use by children age 12 and older. This expanded pediatric indication applies to the current t:slim Pump features, with … Read more

New Medtronic Guardian Connect Mobile CGM System Approved in EU

Medtronic Guardian Connect

Medtronic has received CE (Conformité Européenne) Mark for its new Guardian Connect mobile continuous glucose monitoring (CGM) system for people with diabetes using insulin injection therapy. Guardian Connect is the first smartphone-enabled CGM system from Medtronic to receive CE Mark and … Read more

FDA Advisory Committee Votes To Approve IDegLira


The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the approval of Novo Nordisk’s IDegLira for the treatment of adults with type 2 diabetes.  IDegLira is a once-daily, single injection fixed combination … Read more

FDA Announces New Nutrition Label

New Nutrition Labels - 2016 - Home

Today the U.S. Food and Drug Administration (FDA) announced a new Nutrition Facts label for most packaged foods that reflects the latest in nutrition science including the link between diet and chronic diseases such as obesity and heart disease. The new … Read more

Invokana May Increase Risk of Leg and Foot Amputations

Invokana Pill Box

The FDA issued a safety communication alerting the public about interim safety results from an ongoing clinical trial that found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with the diabetes medicine canagliflozin (Invokana, Invokamet). … Read more

Insulin Pumps Shown To Improve Type 2 Diabetes Management

Insulin Pumps Shown To Improve Type 2 Diabetes Management - Medtronic 640G

Medtronic Inc. has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study, providing further clinical evidence in support of insulin pumps for people with insulin-requiring type 2 diabetes. The OpT2mise … Read more

LifeScan Introduces New OneTouch Verio Flex Glucometer

OneTouch Vario Flex

LifeScan has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure technology – a simple, accurate and easy-to-use meter that takes the guesswork out of understanding blood sugar test results for people with diabetes.  Its simple color … Read more

Subscribe to our Newsletter

Hide me